(lp0
S"Galectin Therapeutics Inc : Here's What's Important Insider Financial - Apr 10, 2017 Galectin Therapeutics Inc  was a big first quarter winner. The company opened 2017 in and around the dollar mark, and currently trades for around $3.7 - a 185% appreciation during the period.Galectin Therapeutics  Looks Good: Stock Jumps 16.7% - Yahoo FinanceGalectin Therapeutics, Inc. closed with a change of 5.92% in the Previous ... - Free Observer"
p1
aS'Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update GlobeNewswire  - Mar 28, 2017 NORCROSS, Ga., March 28, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today reported financial results for the year ended December 31, 2016.Buy or Sell? What Analysts Recommends: Galectin Therapeutics, Inc. , SEI ... - StockNewsJournalGalectin Therapeutics Inc  Given Average Rating of  by Brokerages - The Cerbat Gem'
p2
aS'Galectin Therapeutics to Present at 29th Annual ROTH Conference GlobeNewswire  - Mar 9, 2017 NORCROSS, Ga., March 09, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin, Ph.'
p3
aS"Why Galectin Therapeutics Just Lost Nearly Half Its Market Cap Benzinga - Sep 28, 2016 Shares of Galectin Therapeutics Inc , a clinical-stage biopharmaceutical company that creates therapies for fibrotic disease and cancer, tumbled nearly 50 percent on Wednesday after the company said that a Phase 2a study called NASH-FX&nbsp;...Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot ... - GlobeNewswire Stock Update : Here's Why Galectin Therapeutics Inc Shares Are ... - Smarter Analyst"
p4
aS'Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial ... GlobeNewswire  - Mar 21, 2017 NORCROSS, Ga., March 21, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today that the Company will release fourth quarter and full year 2016&nbsp;...Analyst Observation On 2 Stocks: Curis, Inc. , Galectin Therapeutics ... - Post AnalystGalectin Therapeutics Inc  Given Average Rating of  by Analysts - Sports Perspectives'
p5
aS'Akari Therapeutics, Galectin Therapeutics Receive Positive Financial News Yahoo Finance - Apr 3, 2017 Galectin Therapeutics advanced 13.30% to close at $2.30 on Friday. The stock traded between $2.100 and $2.30 on a volume of 989,444 shares traded.'
p6
aS'Galectin Therapeutics Inc  Is An Alternative Catalyst Play Insider Financial - Feb 16, 2017 Galectin Therapeutics Inc  is drawing some considerable volume at the moment, and the company is up more than 45% this week alone as a result.'
p7
aS'Ticker Scope: Tracking Shares of Galectin Therapeutics, Inc.  Benton Bulletin - 13 hours ago Interested investors may be tracking the Piotroski F-Score. Galectin Therapeutics, Inc.  currently has a Piotroski F-Score of 2. The aim of the F-Score is to help discover companies with strengthening balance sheets, and to eliminate the ...'
p8
aS'Galectin Therapeutics and Axovant Sciences See Stocks Rise on Investor Optimism Yahoo Finance - Apr 11, 2017 Galectin Therapeutics advanced 5.92% to close at $3.04 on Monday. The stock traded in a wide range between $2.75 and $3.68 on a volume of 4.1 million shares traded.'
p9
aS'Galectin Therapeutics Announces Achievement of Key Milestones Related to NASH ... GlobeNewswire  - Feb 1, 2017 NORCROSS, Ga., Feb. 01, 2017  -- Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, today announced it has generated sufficient financing to cover currently planned&nbsp;...'
p10
a.